Results shown below
Barriers faced by children and young people living with sickle cell as they transition from NHS paediatric to adult health care providers are set to be explored and tackled.
First Do No Harm, the independent review of the safety of medicines and medical devices led by Baroness Julia Cumberlege, found that patients’ voices were ignored, and that the health system did not listen and act, but was defensive, dismissive, and disjointed. As the first ever Patient Safety Commissioner I have been listening to patients and patient safety experts to understand what needs to improve.
A landmark independent review of services provided by NHS Talking Therapies has identified that psychotherapy services need better tailoring to meet the needs of Black and minoritised ethnic groups.
Gypsy, Roma and Traveller communities face some of the most stark inequalities in access to healthcare in England and remain subject to dire mental health outcomes.
The Windrush Generation endured the worst of racism and anti-blackness. It wasn’t just the ‘colour bar’ ‘that they endured but the ongoing issues of the impact of empire and colonisation. And we need to recognise, too, that racism and injustice can still be experienced today.
As the Patient Safety Commissioner, my role is to champion the voice of patients and my goal is that every patient will feel that their voice and views matter – and that means all patients.
General interventions and medications such as hydroxyurea, morphine and blood transfusions were hit and miss, usually giving relief for a period but the sickling would return with vengeance.
Over the years, having reached a point of exasperation, I accepted the struggle, hurdles and challenges to overcome can’t take place in isolation.
With equal pay at its heart, how much has Agenda for Change helped with differences in pay across the NHS’s ethnically diverse workforce?
A new pilot project aimed at increasing the number of Black, Asian and ethnic minority patients taking part in potentially life-enhancing breast cancer clinical trials has been announced today, 31 August.
